科技期刊对论文摘要的要求
摘要
根据有关规定，可以把摘要编写要求归纳成如下几点。省略“我们”“作者”“本文”这样的主语。
出处
《国际眼科杂志》
CAS
2013年第11期2239-2239,共1页
International Eye Science
二级参考文献22
-
1The central vein occlusion study group.Natural history and clinical management of central retinal vein occlusion,1997.
-
2The central vein occlusion study group.A randomized clinical trial of early panretinal photocoagulation for ischemic central Vein Occlusion,1995.
-
3Aiello LP,Avery RL,Arrigg PG,et al.Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Homeopathy . 1994
-
4Hamid Ahmadieh,Alireza Ramezani,Nasser Shoeibi,Bijan Bijanzadeh,Ali Tabatabaei,Mohsen Azarmina,Masoud Soheilian,Gholamreza Keshavarzi,Mohammad-Reza Mohebbi.Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial[J]. Graefe’s Archive for Clinical and Experimental Ophthalmology . 2008 (4)
-
5Fegan CD.Central retinal vein occlusion and thrombophilia. Eye (Lond) . 2002
-
6Andreas Stahl,Hansjürgen Agostini,Lutz L. Hansen,Nicolas Feltgen.Bevacizumab in retinal vein occlusion-results of a prospective case series[J]. Graefe’s Archive for Clinical and Experimental Ophthalmology . 2007 (10)
-
7Alireza Ramezani,Morteza Entezari,Siamak Moradian,Homa Tabatabaei,Shohreh Kadkhodaei.Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial[J]. Graefe’s Archive for Clinical and Experimental Ophthalmology . 2006 (12)
-
8Bearelly S,Fekrat S.Controversy in the management of retinal venous occlusive disease. International Ophthalmology Clinics . 2004
-
9Campochiaro PA,Hafiz G,Shah SM,Nguyen QD,Ying H,Do DV,Quinlan E,Zimmer- Galler I,Haller JA,Solomon SD,Sung JU,Hadi Y,Janjua KA,Jawed N,Choy DF,Arron JR.Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Molecular Therapy . 2008
-
10Gregori NZ,Gaitan J,Rosenfeld PJ,Puliafito CA,Feuer W,Flynn HW Jr,Berrocal AM,Al- Attar L,Dubovy S,Smiddy WE,Schwartz SG,Lee WH,Murray TG.Long- term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion. Retina . 2008
共引文献7
-
1Marianne L. Shahsuvaryan.Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion[J].International Journal of Ophthalmology(English edition),2012,5(6):759-770. 被引量：16
-
2Marianne L.Shahsuvaryan.玻璃体内注射药物对视网膜静脉阻塞的治疗(英文)[J].国际眼科杂志,2013,13(1):18-29. 被引量：4
-
3郑燕林,高明敏,毛奕茜,王晶,姚曼.曲安奈德联合激光及中药治疗视网膜中央静脉阻塞性黄斑水肿的临床研究[J].中国中医眼科杂志,2013,23(1):28-31. 被引量：8
-
4张璐,赵博军.视网膜静脉阻塞引起黄斑水肿的药物治疗进展[J].国际眼科杂志,2013,13(11):2227-2230. 被引量：9
-
5周琳,王立,彭超,伍宇华,黄欢.视网膜静脉阻塞诊断与颈动脉狭窄相关研究[J].中外医疗,2014,33(15):183-185. 被引量：1
-
6Liu Xiangdong Zhou Xiaodong Wang Zhi Li Tao Jiang Bo.Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema： a meta-analysis of randomized controlled trials[J].Chinese Medical Journal,2014(19):3471-3476. 被引量：7
-
7Sever Ozkan,Horozoglu Fatih,Celik Erkan,Topcu Birol.贝伐单抗单用与联合曲安奈德治疗糖尿病性黄斑水肿的疗效比较（英文）[J].国际眼科杂志,2019,19(1):1-8. 被引量：1
-
1《中医教育》对摘要的编写要求[J].中医教育,2005,24(4):84-84.
-
2论文题名的编写要求[J].中国药物滥用防治杂志,2004,10(1):47-47.
-
3《中医教育》对摘要的编写要求[J].中医教育,2007,26(4):67-67.
-
4《中医教育》对摘要的编写要求[J].中医教育,2007,26(6):9-9.
-
5《中医教育》对摘要的编写要求[J].中医教育,2009(2):13-13.
-
6论文摘要编写要求[J].山西中医,2005,21(3):59-59.
-
7《中医教育》对摘要的编写要求[J].中医教育,2007,26(2):78-78.
-
8《中医教育》对摘要的编写要求[J].中医教育,2005,24(2):33-33.
-
9《中医教育》对摘要的编写要求[J].中医教育,2007,26(3):31-31.
-
10《中医教育》对摘要的编写要求[J].中医教育,2005,24(5):52-52.
